CERE
Cerevel Therapeutics Holdings, Inc.
CEO and Chair N Anthony Coles sold $1.5M of Cerevel Therapeutics Holdings, Inc.
Sold$1,496,871
$29.94Price
50,000Shares
−95%Stake
What CERE did after the filing
- The stock from Fri, Jan 6 close, $30.74
- +0.8%
- S&P 500, same days
- +2.8%
Measured over 30 trading days, to the Feb 21 close.
Traded Thu, Jan 5. Filed Fri, Jan 6, 12:04 PM ET, during the session. Returns use the Jan 6 close and the Feb 21 close. Not investment advice.